Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
about
KASL clinical practice guidelines: management of chronic hepatitis BAssociation of Lymphomagenesis and the Reactivation of Hepatitis B Virus in Non-Hodgkin LymphomaPrevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapyUpdate on occult hepatitis B virus infectionHepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-ScreenedDetection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected IndividualsHepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin's lymphoma.PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control studyChemotherapy-related reactivation of hepatitis B infection: updates in 2013.Positive association between hepatitis C infection and oral cavity cancer: a nationwide population-based cohort study in Taiwan.Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapyLymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturationHepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases.Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control StudyHigh prevalence of hepatitis B virus infection in primary central nervous system lymphoma.Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals: clues for possible immunosuppression-related or infectious etiology.Epidemiologic overview of malignant lymphoma.Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan.Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphomaEfficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study.Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy.Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regionsThe status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer.Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOP.Moving forward in HIV-associated cancer.Optimizing antiviral agents for hepatitis B management in malignant lymphomas.The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.Viral infections and their management in patients with chronic lymphocytic leukemia.Consecutive stimulation of HBsAg promotes the viability of the human B lymphoblastoid cell line IM-9 through regulating the SIRT1-NF-κB pathway.The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.Cancer statistics for Hispanics/Latinos, 2015.Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.Treatment of synchronous adenocarcinoma and lymphoma of the stomach: A case reportAssociation of Human Cytomegalovirus with Hodgkin’s Disease and Non-Hodgkin’s lymphomasA comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.
P2860
Q26752475-0C23013B-4B8A-4260-8605-3FE1B9C6CD6AQ26782217-FDFEE45A-11A4-48A3-8D98-1F6FDEAC9578Q28070090-C6C535BC-0835-4EFD-9685-A7A2A23DF50DQ28070317-36F91B88-A5D7-4730-B727-256B83FFC04BQ28076703-EDD1251E-F9E8-4E05-8711-9B65A63B4EC7Q28548313-454FE0DD-8D5D-4035-815F-A855D37E4D1BQ33564294-16F75FBC-A575-4C0B-950E-34476B6736E3Q33853605-3C5A8B1E-910F-4B56-B64C-0C09E24218D9Q33935351-36652F12-3FE4-42D9-93F2-67261B4B0DA8Q34083182-D8D6DF22-F4D7-43A6-A8D1-247B6C4EE36EQ34404991-9125566C-A498-4F1C-9F87-F862EB7E7A92Q34469335-08AC76CB-D8A4-40E8-9DAA-6BAB84FB6C9BQ34828556-57ED2442-318E-4DBB-ADFE-A0B7F5FDE539Q35036813-605B7E79-E770-4F35-B492-BEA879DDBB9BQ35274812-701925ED-9C67-4188-8FDB-11EA95B239BCQ35794786-C9D0AFB2-FCFB-4C91-BA4E-D7CC7C4ED8C9Q35959066-A2E79476-2B7D-4420-B59D-212630FE941AQ36004602-34882BC7-32CF-493B-9910-7734B62396A7Q36074055-0CF808C2-9521-470A-9349-A4C1BF326412Q36121117-E4DC92E6-6B8E-4777-BB0E-546A884D649CQ36153966-B273F2D4-2162-42C0-A0A5-A151D38B1DFAQ36184703-F2E43E6B-5E5D-4F8F-A972-18969E7A2D6BQ36413119-AD18B052-3334-4560-850B-92F3BA62B73AQ36584311-9295400F-773C-46F0-B4B6-268E02736586Q36705558-693C4BBC-B7C1-45F3-97C4-1B444653887AQ37031355-DF2461E5-3E20-45D3-9DB8-4D5E7034CDDAQ37287479-DD3805F6-F8C1-4418-9590-7877C71A6396Q37365328-08DBE0E2-C1A6-49E6-938F-9027BAC82B25Q37618985-FD206593-A7C2-4943-B7F8-5E1012E46AE9Q37627688-B61BBA6A-8530-4D5A-9473-B2779F40429EQ37666948-FC3F7F86-5628-4358-9B2C-FCD766D291C7Q37995199-95233BD9-FFAA-4E2A-B85C-289DA0CDC310Q38064527-54D4EC8C-E784-42E3-A4FD-D95B1A857C90Q38697681-71FD5D81-2658-42F3-A094-43F29A60E060Q38856104-F7DF6023-5102-4EE7-B536-15520519372BQ38963293-2DA1B3B9-5BF5-40DC-AD9B-DBD41A9EC64BQ39090949-79F4648D-A914-463E-AA88-B49D53E81B5CQ39094321-923C9AF4-A263-488A-9BAC-7D26E11CB35BQ39241141-5E32A6BA-7416-4177-BE2D-C5C0EC3D8CD8Q40122859-867A7AA1-C742-410B-A352-E1B0FB7FF0B9
P2860
Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@ast
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@en
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@nl
type
label
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@ast
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@en
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@nl
prefLabel
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@ast
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@en
Hepatitis B virus infection an ...... n South Korea: a cohort study.
@nl
P2860
P1433
P1476
Hepatitis B virus infection an ...... in South Korea: a cohort study
@en
P2093
Eo Rin Cho
Eric A Engels
P2860
P304
P356
10.1016/S1470-2045(10)70167-4
P50
P577
2010-08-03T00:00:00Z